Regencell Bioscience Holdings Limited (RGC)
RGC trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.19
+14.87% on the day
Market cap
$4.1B
Mid cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | RGC on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | Hong Kong |
| IPO year | 2021 |
| SEC CIK | 0001829667 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | E9 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-05-19 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-10-07 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-05-22 |
Source: SEC EDGAR submissions feed, 85 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +12.8% |
| 1 month | +43.2% |
| 3 months | +67.8% |
| Year to date | -61.8% |
| 1 year | -55.4% |
| From 52-week high | -84.8% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DFTX | Definium Therapeutics Inc. Common Shares | $34.38 | -2.33% | $4.6B |
| RLX | RLX Technology Inc. | $1.71 | -0.58% | $2.1B |
| TRLV | Trulieve Cannabis Corp. Subordinate Voting Shares | $10.11 | -2.69% | $1.9B |
| CRON | Cronos Group Inc. Common Share | $3.20 | -0.31% | $1.2B |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
| OBIO | Orchestra BioMed Holdings Inc. | $5.72 | -3.21% | $343.8M |
| GLAS | Glass House Brands Inc. Subordinate Voting Shares | $3.85 | -5.64% | $338.8M |
| CGC | Canopy Growth Corporation Common Shares | $0.7625 | +0.66% | $322.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier